Location History:
- Dublin, IE (1990 - 1992)
- Clonsilla, IE (1994)
Company Filing History:
Years Active: 1990-1994
Title: Joseph G Masterson: Innovator in Transdermal Drug Delivery
Introduction
Joseph G Masterson is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of transdermal drug delivery, holding a total of four patents. His innovative approaches aim to improve the treatment of withdrawal symptoms associated with smoking and enhance drug delivery methods.
Latest Patents
One of Masterson's latest patents is a method for the treatment of withdrawal symptoms associated with smoking. This preparation allows for the once-daily, percutaneous administration of nicotine, which is uniformly distributed in a solid, semi-solid, or mucilaginous medium. This medium can be placed in intimate contact with the skin, providing an effective method for treating withdrawal symptoms and combating psychological dependence on smoking. Another significant patent is a transdermal drug delivery device. This device features a detachably mounted electrode that facilitates the passage of a drug substance through the skin under the influence of iontophoretic or electro-osmotic forces. The electrode is designed for optimal contact with human skin, ensuring effective drug delivery.
Career Highlights
Throughout his career, Joseph G Masterson has worked with prominent companies such as Elan Transdermal Limited and Elan Corporation, Plc. His work in these organizations has allowed him to develop and refine his innovative ideas in drug delivery systems.
Collaborations
Masterson has collaborated with notable professionals in his field, including Yvonne B Bannon and John Corish. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Joseph G Masterson is a distinguished inventor whose work in transdermal drug delivery has the potential to significantly impact the treatment of smoking withdrawal symptoms. His innovative patents and collaborations highlight his commitment to advancing medical technology.